Elevated levels of CCL2 are often associated with the progression of diseases, such as esophageal cancer, breast cancer, colorectal cancer, prostate cancer, melanoma, gastric cancer, and ovarian cancer [40]. Here, CCL2 is linked to prostate cancer.